🇺🇸 FDA
Pipeline program

Group A FMP2.1/AS01B

WRAIR 1280

Phase 2 mab completed

Quick answer

Group A FMP2.1/AS01B for Malaria is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Malaria
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials